Abstract
Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Current Respiratory Medicine Reviews
Title:COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Volume: 9 Issue: 2
Author(s): Asif Najmuddin, Naga Sirikonda and Harakh V. Dedhia
Affiliation:
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Abstract: Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Export Options
About this article
Cite this article as:
Najmuddin Asif, Sirikonda Naga and Dedhia V. Harakh, COPD Evaluation: Beyond the Airway Obstruction, a Follow Up, Current Respiratory Medicine Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573398X113099990002
DOI https://dx.doi.org/10.2174/1573398X113099990002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: [Hot Topic: Establishment of the Australian Infectious Diseases Research Centre]
Current Drug Targets Editorial (Hot Topic: Vitamin D Deficiency and Critical Illness)
Inflammation & Allergy - Drug Targets (Discontinued) Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Fatty Acids and Obesity
Current Pharmaceutical Design Catecholamines, Sympathetic Innervation and Immunity: Role in Experimental and Rheumatoid Arthritis
Letters in Drug Design & Discovery Psychoemotional Background of Temporomandibular Joint Dysfunction and Possible Drug Therapy
Letters in Drug Design & Discovery Vasorelaxant and Antihypertensive Effects of <i>Mentha pulegium</i> L. in Rats: An In vitro and In vivo Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Extraction of Triacylglycerols and Fatty Acids Using Supercritical Fluids - Review
Current Analytical Chemistry Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core
Current Topics in Medicinal Chemistry Combination of Captopril with Gliclazide Decreases Vascular and Renal Complications and Improves Glycemic Control in Rats with Streptozotocin- Induced Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets HM74a Agonists: Will they be the New Generation of Nicotinic Acid?
Current Topics in Medicinal Chemistry Is there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review
Current Vascular Pharmacology Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia
Current Vascular Pharmacology An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases
Current Medicinal Chemistry Non-pharmacological Strategies Against Systemic Inflammation: Molecular Basis and Clinical Evidence
Current Pharmaceutical Design Women Tipping the Scale During Pregnancy: A Special Population for Obesity Interventions,Treatments and Clinical Trials
Current Pharmaceutical Design Amiodarone Hepatotoxicity
Current Vascular Pharmacology